Regarding the oral medicine for the new coronavirus developed by Shionogi Pharmaceutical, the expert meeting of the Ministry of Health, Labor and Welfare has agreed to approve its use, and it is expected to be approved after this.
The feature is that it can be taken from the mild stage even for patients with a low risk of becoming severe, and it is the first oral drug developed by a domestic pharmaceutical company.
The drug approved for use is Zokoba, an oral drug for the new coronavirus developed by Shionogi.
This drug is an oral drug for the new coronavirus that can be taken from the mild stage, and unlike previous drugs that were targeted at patients with a high risk of becoming severe, it is characterized by the fact that it can be taken by patients with a low risk of becoming severe. .
After an application for approval for use was filed in February this year, it was deliberated in June and July under the `` emergency approval '' system for quickly approving developed drugs in an emergency. The decision was postponed and continued deliberations, and Shionogi subsequently submitted new results of the final stage clinical trials to the Ministry of Health, Labor and Welfare.
At an expert meeting of the Ministry of Health, Labor and Welfare held today (22nd), it was recognized that it was effective in improving symptoms such as fever. Did.
After this, the Ministry of Health, Labor and Welfare is expected to approve it, and it will be the first oral drug developed by a domestic pharmaceutical company.
The Ministry of Health, Labor and Welfare has signed a contract to purchase 1 million doses from Shionogi after approval, and it is expected that supply to medical institutions will begin in the future.